Galapagos NV. Daily Stock Analysis

Daily Stock Analysis, GLPG, Galapagos NV, priceseries

Galapagos NV. Daily Stock Analysis
Stock Information
Open
59.16
Close
59.00
High
60.12
Low
58.50
Previous Close
61.44
Daily Price Gain
-2.44
YTD High
69.50
YTD High Date
Feb 10, 2022
YTD Low
50.32
YTD Low Date
Jan 10, 2022
YTD Price Change
4.10
YTD Gain
7.47%
52 Week High
85.46
52 Week High Date
Mar 9, 2021
52 Week Low
46.41
52 Week Low Date
Dec 3, 2021
52 Week Price Change
-21.67
52 Week Gain
-26.86%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 23. 2016
63.03
Jan 19. 2017
67.20
16 Trading Days
6.62%
Link
LONG
Mar 1. 2017
71.78
Apr 18. 2017
87.52
33 Trading Days
21.92%
Link
LONG
Aug 11. 2017
83.73
Sep 21. 2017
100.21
28 Trading Days
19.69%
Link
LONG
Jan 4. 2018
97.33
Feb 5. 2018
114.59
21 Trading Days
17.73%
Link
LONG
May 11. 2018
92.89
May 29. 2018
98.45
11 Trading Days
5.98%
Link
LONG
Jun 27. 2019
127.56
Jul 31. 2019
173.53
23 Trading Days
36.04%
Link
LONG
Oct 24. 2019
164.27
Nov 14. 2019
185.90
15 Trading Days
13.17%
Link
LONG
Nov 25. 2019
190.49
Dec 13. 2019
209.61
13 Trading Days
10.04%
Link
LONG
Jan 14. 2020
211.73
Jan 30. 2020
227.64
11 Trading Days
7.52%
Link
LONG
Mar 25. 2020
175.82
Apr 28. 2020
208.85
23 Trading Days
18.79%
Link
LONG
Dec 14. 2021
50.29
Jan 3. 2022
54.05
13 Trading Days
7.47%
Link
Company Information
Stock Symbol
GLPG
Exchange
NasdaqGS
Company URL
http://www.glpg.com
Company Phone
-
CEO
Onno van de Stolpe
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001421876
About

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-service segments. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Description

Belgian biotech developing new treatments for inflammatory diseases.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading